gene defect

Objective To study gene defect of a hereditary coagulation factor XIII deficiency family .

目的研究一例遗传性凝血因子XIII（FXIII）缺陷症家系的基因缺陷。

Gene defect during embryonic period may interfere the growth of osteoepiphysis .

可能为胚胎期基因缺陷致骨骺生长层发育障碍。

Studies on the gene defect of Hereditary deficiency of factor V

遗传性因子V缺乏症的基因研究

Study in mitochondrial gene defect of patients with mitochondrial myopathy and encephalomyopathy

线粒体肌病和脑肌病患者线粒体基因缺失的研究

The relationship between mitochondrial gene defect and the development of diabetes mellitus has been widely attended .

线粒体基因缺陷与糖尿病发生发展的关系日益受到关注。

It is found that some patients with pre-eclampsia maybe have HLA-G gene defect , and the distribution of HLA-G polymorphism was also different .

发现部分子痫前期患者可能存在HLAG基因缺陷，且HLAG多态性在子痫前期及正常妊娠者中分布也不同。

There are a variety of fish vaccines . In addition to traditional vaccines , new vaccines include synthesis peptide vaccine ,, DNA vaccine , gene defect vaccine , and so on .

鱼用疫苗的种类繁多，除传统疫苗之外，新型疫苗包括合成肽疫苗、DNA疫苗、活载体疫苗、基因缺失疫苗等。

Application of Gene Knockout and Gene Defect Models in the Study of Drug Membrane Transport

基因敲除与基因突变动物模型在药物跨膜转运研究中的应用

Gene therapy for bone defect

骨缺损的基因治疗

Bone morphogenetic protein-2 released from carrier or gene could repair bone defect effectively .

载体或基因释放的骨形态发生蛋白2可有效修复骨缺损。

Inclusion criteria were ① researches on gene therapy for bone defect and ② researches on histological engineering of bone .

纳入标准：①有关骨缺损的基因治疗研究。②有关骨组织工程研究。

Protein tyrosine kinase of focal adhesion kinase subfamily-a new related gene of ventricular septal defect

室间隔缺损新的相关基因-蛋白酪氨酸激酶的实验研究

The gene therapy for bone defect , which overcomes the restriction of traditional therapies , has fatal research significance .

骨缺损的基因治疗克服了传统治疗方法的局限，具有重要研究意义。

Objective To construct the IFN-2a-GFE-1 fusion gene vector , and defect its expression in transfected providing the data for targeted-drug therapy .

目的构建IFN-α2a-GFE-1融合基因载体，检测其在转染细胞的表达，为肺癌基因导向药物治疗积累实验资料。

CONCLUSION Bicistronic eukaryotic expression plasmids containing BMP-2 and VEGF-165 mRNA are constructed successfully which provide the foundation for combination gene therapy in bone defect .

结论：成功构建了可同时表达骨形态发生蛋白2及血管内皮生长因子165的双基因真核表达质粒，为进行联合基因治疗骨缺损的实验研究奠定了基础。

Basic study of gene therapy in the defect of bone , muscle tissue : Recombinant adenoviral type 5 vectors containing both cmv promotor and transforming growth factor - β 1 production

基因疗法治疗骨骼、肌肉组织缺损的基础研究：重组复制缺陷型腺病毒载体Ad5/CMV-TGF-β1的构建

We reviewed the recent advances made in research on bone morphogenic protein regarding its mechanism of osteogenesis and on effect of combined human bone and local gene therapy in bone defect repairing .

综述骨形态发生蛋白（BoneMorphogenicProtein，BMP）的成骨机理及其复合人工骨和局部基因疗法在治疗骨缺损中的研究进展。

The work of this paper shows that : the method , which optimizes PID control of self-adapted Ant colony algorithm based on genetic gene , overcomes the defect of Ant colony algorithm and can optimized PID control parameter well .

本文的工作表明：具有遗传因子的自适应蚁群算法最优PID控制参数的方法，克服了蚁群算法的不足，能够满意地实现PID控制参数优化、仿真结果与Z-N法，遗传算法相比较。

DATA SYNTHESIS : The regional gene therapy of bone defect is a new technique developed base on the basic theoretical cognition of bone regeneration and gene recombination technique , and provides ideal solving program for the treatment of bone defect caused by various reasons .

资料综合：骨缺损的局部基因治疗是在骨再生基本理论认识和基因重组技术基础上发展起来的新技术，为各种原因造成的骨缺损的治疗提供理想的解决方案。